semaglutide что это Семаглутид: механизм работы и особенности применения Семаглутид | ЦДПО InstructorPRO

semaglutide reduces both risks simultaneously

After that, a doctor may increase the dose depending on blood sugar response and tolerability

Clinical Studies 3.1

More recently, tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist, has demonstrated superior weight-reducing effects compared with both placebo and semaglutide, particularly in the SURMOUNT trials, with these benefits sustained for up to 72 weeks [79,80,81]

Second-generation GLP-1 drugs contain an added hormone, gastrointestinal inhibitory peptide (GIP), which further enhances the bodys ability to manage blood sugar and shed weight